javygtor

Generic: sapropterin dihydrochloride

Labeler: dr. reddys laboratories inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name javygtor
Generic Name sapropterin dihydrochloride
Labeler dr. reddys laboratories inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

sapropterin dihydrochloride 100 mg/1

Manufacturer
Dr. Reddys Laboratories Inc

Identifiers & Regulatory

Product NDC 43598-096
Product ID 43598-096_ce2e0e3a-40e4-33ed-3cad-e166dd2245a1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207685
Listing Expiration 2026-12-31
Marketing Start 2022-10-03

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] p-glycoprotein inhibitors [moa] phenylalanine hydroxylase activator [epc] phenylalanine hydroxylase activators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598096
Hyphenated Format 43598-096

Supplemental Identifiers

RxCUI
1486687 2612671
UPC
0343598096049
UNII
RG277LF5B3

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name javygtor (source: ndc)
Generic Name sapropterin dihydrochloride (source: ndc)
Application Number ANDA207685 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (43598-096-04)
  • 500 TABLET in 1 BOTTLE (43598-096-05)
  • 30 TABLET in 1 BOTTLE (43598-096-30)
source: ndc

Packages (3)

Ingredients (1)

sapropterin dihydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ce2e0e3a-40e4-33ed-3cad-e166dd2245a1", "openfda": {"upc": ["0343598096049"], "unii": ["RG277LF5B3"], "rxcui": ["1486687", "2612671"], "spl_set_id": ["d9f3723f-bf7d-9a72-2ef9-41c5508d6ab4"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (43598-096-04)", "package_ndc": "43598-096-04", "marketing_start_date": "20221003"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (43598-096-05)", "package_ndc": "43598-096-05", "marketing_start_date": "20221003"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (43598-096-30)", "package_ndc": "43598-096-30", "marketing_start_date": "20221003"}], "brand_name": "JAVYGTOR", "product_id": "43598-096_ce2e0e3a-40e4-33ed-3cad-e166dd2245a1", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Phenylalanine Hydroxylase Activator [EPC]", "Phenylalanine Hydroxylase Activators [MoA]"], "product_ndc": "43598-096", "generic_name": "Sapropterin Dihydrochloride", "labeler_name": "Dr. Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JAVYGTOR", "active_ingredients": [{"name": "SAPROPTERIN DIHYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA207685", "marketing_category": "ANDA", "marketing_start_date": "20221003", "listing_expiration_date": "20261231"}